pharmaceutical
RSS pharmaceuticalSupply Chain Risk Assessment
White Paper For pharmaceutical, life sciences, and medical device companies, supply chain breakdowns not only bring immediate damage to the affected company, but also can threaten human health and well-being by causing medical... [13 Nov 2009]
The ROI of Data Loss Prevention
White Paper IP is the heart of today's technology, manufacturing, pharmaceutical, and even financial firms, and their most coveted sustainable advantage. One data loss incident can result in continuous cost. After making affected... [13 Nov 2009]
Pharmaceutical Shifts Towards UHF RFID for Savings
White Paper The pharmaceutical industry in the United States dispensed more than $260 billion worth of prescription medications in 2008, and in the global marketplace the total is more than twice that amount. Distributing regulated... [12 Nov 2009]
Identity Validation for the Biopharmaceutical Industry
White Paper In 2004, the Pharmaceutical Research and Manufacturers of America (PhRMA) reported that 40% of all Research and Development costs are attributed to paper based business processes, representing $9 Billion in the U.S.alone. [12 Nov 2009]
Data Reduction Systems: Easy-to-Use CRM System Spurs Employee Data Tracking, Improves Information Accuracy
White Paper New Jersey-based Data Reduction Systems provides data storage archival and retrieval solutions to businesses, including support for server-based business operations such as accounting and solutions specifically for... [28 Oct 2009]
Digital Signatures for the Pharmaceutical Industry
White Paper Typical examples of digital signature use within the pharmaceutical industry include systems and processes such as electronic submissions, RA/QA, Standard Operating Procedures (SOPs), clinical operations, manufacturing... [02 Oct 2009]
Dell Services Help Worldwide Medical Research Company ICON Clinical to Speed Its Software Image Updating Process by 50 Percent
White Paper Many of the world's top pharmaceutical and biotechnology companies depend on ICON Clinical plc (ICON) for strategic development, management, and analysis of programs that support clinical development - from compound... [02 Oct 2009]
Partner Wins New ERP Business With Valuable Help From Technical Sales Assistance Team
White Paper An Abakion customer in the pharmaceutical industry was planning to build a new production plant for a medical product it wanted to sell in the United States. Abakion is a Microsoft Gold Certified Partner that specializes... [01 Oct 2009]
Orexigen Selects GlobalSign's DocumentSign Services to Secure Sensitive Documentation
White Paper Nasdaq: OREX) is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of Central Nervous System (CNS) disorders, including obesity. Orexigen Therapeutics, Inc. [01 Oct 2009]
Lilly and SAS: A 30-Year Relationship
White Paper At Eli Lilly and Company, the success of its innovative pharmaceutical products is measured in the Indianapolis-based drug manufacturer's ability to improve the quality of life for patients and their families. [19 Sep 2009]
Sanofi-Aventis Brings Products to Market More Rapidly With SAS
White Paper That's the slogan of the second largest pharmaceutical group in France. "Because Health Matters. With a presence in 100 countries and more than 30,000 employees worldwide, Sanofi-Aventis had consolidated annual sales of ? [19 Sep 2009]
AstraZeneca: Easy Access to Production Info With SAS
White Paper AstraZeneca has 56,000 employees across the globe - is one of the world's leading pharmaceutical companies. The challenge was to reduce manufacturing costs while ensuring fast, reliable reporting and analytics. [19 Sep 2009]
Top Ten Reports in Clinical Performance Management
White Paper Finding ways to reduce the cost of clinical trials is on the agenda of every pharmaceutical company striving to remain profitable. This white paper outlines the ten critical CPM reports every... [16 Sep 2009]
A Revolution in Physician Targeting: In-Source Analytics-Driven Intelligence to Go Beyond Decile-Based Targeting
White Paper Most pharmaceutical companies focus their sales and marketing activities on the top decile prescribing physicians for a given therapeutic area, based on purchased data. Others are experimenting with newer data sets, such... [16 Sep 2009]
A New Course of Treatment to Maximize Efficiency - SAS for Life Sciences Sales and Marketing: Exploiting Proven Data Integration and Analytics to Ensure Healthy Returns on Sales and Marketing
White Paper With competing drugs fighting for the attention of physicians, patients and payers - and a limited window of opportunity before patents expire - pharmaceutical companies have no margin for error in implementing their... [16 Sep 2009]
